Risk factors for fragility fractures in type 1 diabetes.


Journal

Bone
ISSN: 1873-2763
Titre abrégé: Bone
Pays: United States
ID NLM: 8504048

Informations de publication

Date de publication:
08 2019
Historique:
received: 03 12 2018
revised: 17 04 2019
accepted: 24 04 2019
pubmed: 7 5 2019
medline: 4 8 2020
entrez: 7 5 2019
Statut: ppublish

Résumé

To determine clinical diabetes-related risk factors for fragility fractures in type 1 diabetes (T1D). History of bone fragility fractures occurring after T1D diagnosis was assessed by questionnaire in this cross-sectional study in 600 T1D subjects. Glycated hemoglobin A1c (HbA1c) over the previous 5 years was used as an index of long-term glycemic control; complications were adjudicated by physician assessment. Multinomial logistic regression models were used to assess the associations between diabetes-related risk factors and fracture history. One-hundred-eleven patients (18.5%) reported at least one fracture; of these 73.8% had only one and 26.2% had more than one fracture. Average age was 41.9 ± 12.8 years, with even gender distribution; disease duration was 19.9 ± 12.0 years; and BMI was 24.4 ± 3.7 kg/m Poor glycemic control and long exposure to the disease are independent diabetes-related risk factors for multiple bone fractures in T1D.

Identifiants

pubmed: 31059862
pii: S8756-3282(19)30153-X
doi: 10.1016/j.bone.2019.04.017
pii:
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

194-199

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Giulia Leanza (G)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: g.leanza@unicampus.it.

Ernesto Maddaloni (E)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: e.maddaloni@unicampus.it.

Dario Pitocco (D)

Diabetology, Catholic University, Rome, Italy. Electronic address: Dario.pitocco@unicatt.it.

Caterina Conte (C)

Vita-Salute San Raffaele University, Milan, Italy; Clinical Transplant Unit, Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milan, Italy.

Andrea Palermo (A)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: a.palermo@unicampus.it.

Anna Rita Maurizi (AR)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: a.maurizi@unicampus.it.

Angelo Lauria Pantano (AL)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: a.lauria@unicampus.it.

Concetta Suraci (C)

Diabetes Unit, Sandro Pertini Hospital, Rome, Italy.

Maria Altomare (M)

Diabetes Unit, Sandro Pertini Hospital, Rome, Italy.

Rocky Strollo (R)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: r.strollo@unicampus.it.

Silvia Manfrini (S)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: s.manfrini@unicampus.it.

Paolo Pozzilli (P)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy. Electronic address: p.pozzilli@unicampus.it.

Ann V Schwartz (AV)

Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA. Electronic address: aschwartz@psg.ucsf.edu.

Nicola Napoli (N)

Department of Medicine, Unit of Endocrinology and Diabetes, Campus Bio-Medico University of Rome, Italy; Division of Bone and Mineral Diseases, Washington University in St Louis, USA. Electronic address: n.napoli@unicampus.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH